Atlas Trials

A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

Clinical trial NCT01638676 · RECRUITING

Trial details

NCT number
NCT01638676
Sponsor
University of Louisville
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2012-07-01
Primary completion
2025-06-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.